195 related articles for article (PubMed ID: 32875577)
1. What 20 years of research has taught us about the TP53 p.R337H mutation.
Pinto EM; Zambetti GP
Cancer; 2020 Nov; 126(21):4678-4686. PubMed ID: 32875577
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.
Mastellaro MJ; Seidinger AL; Kang G; Abrahão R; Miranda ECM; Pounds SB; Cardinalli IA; Aguiar SS; Figueiredo BC; Rodriguez-Galindo C; Brandalise SR; Yunes JA; Barros-Filho AA; Ribeiro RC
Cancer; 2017 Aug; 123(16):3150-3158. PubMed ID: 28387921
[TBL] [Abstract][Full Text] [Related]
3. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
[TBL] [Abstract][Full Text] [Related]
4. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
5. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.
Assumpção JG; Seidinger AL; Mastellaro MJ; Ribeiro RC; Zambetti GP; Ganti R; Srivastava K; Shurtleff S; Pei D; Zeferino LC; Dufloth RM; Brandalise SR; Yunes JA
BMC Cancer; 2008 Dec; 8():357. PubMed ID: 19046423
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
[TBL] [Abstract][Full Text] [Related]
7. Multiple TP53 p.R337H haplotypes and implications for tumor susceptibility.
Pinto EM; Fridman C; Figueiredo BC; Salvador H; Teixeira MR; Pinto C; Pinheiro M; Kratz CP; Lavarino C; Legal EAMF; Le A; Kelly G; Koeppe E; Stoffel EM; Breen K; Hahner S; Heinze B; Techavichit P; Krause A; Ogata T; Fujisawa Y; Walsh MF; Rana HQ; Maxwell KN; Garber JE; Rodriguez-Galindo C; Ribeiro RC; Zambetti GP
HGG Adv; 2024 Jan; 5(1):100244. PubMed ID: 37794678
[TBL] [Abstract][Full Text] [Related]
8. The Brazilian founder mutation TP53 p.R337H is uncommon in Portuguese women diagnosed with breast cancer.
Giacomazzi J; Correia RL; Palmero EI; Gaspar JF; Almeida M; Portela C; Camey SA; Monteiro A; Pinheiro M; Peixoto A; Teixeira MR; Reis RM; Ashton-Prolla P
Breast J; 2014; 20(5):534-6. PubMed ID: 25052705
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of an inherited cancer predisposition syndrome associated with the germ line TP53 R337H mutation in Paraguay.
Legal EF; Ascurra M; Custódio G; Ayala HL; Monteiro M; Vega C; Fernández-Nestosa MJ; Vega S; Sade ER; Coelho IM; Ribeiro EM; Cavalli IJ; Figueiredo BC
Cancer Epidemiol; 2015 Apr; 39(2):166-9. PubMed ID: 25736369
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
Giacomazzi J; Graudenz MS; Osorio CA; Koehler-Santos P; Palmero EI; Zagonel-Oliveira M; Michelli RA; Scapulatempo Neto C; Fernandes GC; Achatz MI; Martel-Planche G; Soares FA; Caleffi M; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
PLoS One; 2014; 9(6):e99893. PubMed ID: 24936644
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutation p.R337H in gastric cancer tissues of a 12-year-old male child: evidence for chimerism involving a common mutant founder haplotype: case report.
da Silva EM; Achatz MI; Martel-Planche G; Montagnini AL; Olivier M; Prolla PA; Hainaut P; Soares FA
BMC Cancer; 2011 Oct; 11():449. PubMed ID: 22004116
[TBL] [Abstract][Full Text] [Related]
12. Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.
Garritano S; Gemignani F; Palmero EI; Olivier M; Martel-Planche G; Le Calvez-Kelm F; Brugiéres L; Vargas FR; Brentani RR; Ashton-Prolla P; Landi S; Tavtigian SV; Hainaut P; Achatz MI
Hum Mutat; 2010 Feb; 31(2):143-50. PubMed ID: 19877175
[TBL] [Abstract][Full Text] [Related]
13. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
[TBL] [Abstract][Full Text] [Related]
14. Mouse Homolog of the Human
Park JH; Li J; Starost MF; Liu C; Zhuang J; Chen J; Achatz MI; Kang JG; Wang PY; Savage SA; Hwang PM
Cancer Res; 2018 Sep; 78(18):5375-5383. PubMed ID: 30042151
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical tumors associated with the TP53 p.R337H germline mutation can be identified during child-care consultations.
Mastellaro MJ; Ribeiro RC; Oliveira-Filho AG; Seidinger AL; Cardinalli IA; Miranda ECM; Aguiar SS; Brandalise SR; Yunes JA; Barros-Filho AA
J Pediatr (Rio J); 2018; 94(4):432-439. PubMed ID: 28864397
[TBL] [Abstract][Full Text] [Related]
16. TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families.
Cury NM; Ferraz VE; Silva WA
Hered Cancer Clin Pract; 2014 Mar; 12(1):8. PubMed ID: 24625245
[TBL] [Abstract][Full Text] [Related]
17. Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.
Custodio G; Taques GR; Figueiredo BC; Gugelmin ES; Oliveira Figueiredo MM; Watanabe F; Pontarolo R; Lalli E; Torres LF
PLoS One; 2011 Mar; 6(3):e18015. PubMed ID: 21445348
[TBL] [Abstract][Full Text] [Related]
18. Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation.
Figueiredo BC; Sandrini R; Zambetti GP; Pereira RM; Cheng C; Liu W; Lacerda L; Pianovski MA; Michalkiewicz E; Jenkins J; Rodriguez-Galindo C; Mastellaro MJ; Vianna S; Watanabe F; Sandrini F; Arram SB; Boffetta P; Ribeiro RC
J Med Genet; 2006 Jan; 43(1):91-6. PubMed ID: 16033918
[TBL] [Abstract][Full Text] [Related]
19. p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Macedo GS; Vieira IA; Vianna FSL; Alemar B; Giacomazzi J; Brandalize APC; Caleffi M; Volc SM; de Campos Reis Galvão H; Palmero EI; Achatz MI; Ashton-Prolla P
Fam Cancer; 2018 Apr; 17(2):269-274. PubMed ID: 28756477
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.
Fortes FP; Kuasne H; Marchi FA; Miranda PM; Rogatto SR; Achatz MI
Braz J Med Biol Res; 2015 Jul; 48(7):610-5. PubMed ID: 25945745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
